While we cannot rigorously rule out some activity on HDAC1 or HDAC2 at the RGFP966 dose used here, these findings represent novel outcomes of inhibiting HDAC3 in HD mice and complement the work of Thomas and colleagues on motor function and working memory9–11. This evidence concerns the gene HDAC3 and Huntington disease.